Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jan-Quinten Mol"'
Autor:
Jan‐Quinten Mol, Julia van Tuijl, Siroon Bekkering, Laura Rodwell, Gheorghe A. M. Pop, Mihai G. Netea, Niels van Royen, Niels P. Riksen, Saloua El Messaoudi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/1a40ee6e9b894a50824cece00ad022d8
Autor:
Jan-Quinten Mol, Julia van Tuijl, Siroon Bekkering, Charlotte D.C.C. van der Heijden, Sander A.J. Damen, Benjamin C. Cossins, Liesbeth van Emst, Tim M. Nielen, Laura Rodwell, Yang Li, Gheorghe A.M. Pop, Mihai G. Netea, Niels van Royen, Niels P. Riksen, Saloua El Messaoudi
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107183- (2023)
Summary: An increasing number of patients develop an atherothrombotic myocardial infarction (MI) in the absence of standard modifiable risk factors (SMuRFs). Monocytes and macrophages regulate the development of atherosclerosis, and monocytes can ado
Externí odkaz:
https://doaj.org/article/fc49a727a85442d1b19e4779f98bee00
Autor:
Peep Laanmets, Martijn Meuwissen, Niels van Royen, Robert-Jan van Geuns, Cyril Camaro, Steven Teerenstra, Saman Rasoul, Erik Lipsic, Rohit M Oemrawsingh, Peter Damman, Jan-Quinten Mol, Anouar Belkacemi, Rick HJA Volleberg, Alexey V Protopopov, Oleg V Krestyaninov, Robert Dennert, Jan-Peter van Kuijk, Karin Arkenbout, Dirk J van der Heijden, Maarten AH van Leeuwen
Publikováno v:
BMJ Open, Vol 11, Iss 7 (2021)
Introduction In patients with myocardial infarction, the decision to treat a nonculprit lesion is generally based on its physiological significance. However, deferral of revascularisation based on nonischaemic fractional flow reserve (FFR) values in
Externí odkaz:
https://doaj.org/article/4ecd73d894314701ac1cf89645a91168
Publikováno v:
Journal of Interventional Cardiology, Vol 2020 (2020)
Objectives. To assess the safety and efficacy of pre-emptive treatment of optical coherence tomography- (OCT-) derived vulnerable, non-flow-limiting, non-culprit lesions in patients with myocardial infarction (MI). Background. Intracoronary imaging w
Externí odkaz:
https://doaj.org/article/820d51313e0149108adb370fb341f482
Autor:
Jan-Quinten Mol, Maarten A.H. van Leeuwen, Shengxian Tu, Niels Ramsing Holm, Martijn Meuwissen, Tom Adriaenssens, Rick Hja Volleberg, Dirk J. van der Heijden, Gregg W. Stone, Niels van Royen, Robert-Jan van Geuns, Crea Filippo, Javier Escaned
Publikováno v:
Trends in Cardiovascular Medicine, 33, 2, pp. 92-106
Trends in Cardiovascular Medicine, 33, 92-106
Volleberg, R, Mol, J Q, van der Heijden, D, Meuwissen, M, van Leeuwen, M, Escaned, J, Holm, N, Adriaenssens, T, van Geuns, R J, Tu, S, Crea, F, Stone, G & van Royen, N 2023, ' Optical coherence tomography and coronary revascularization : from indication to procedural optimization ', Trends in Cardiovascular Medicine, vol. 33, no. 2, pp. 92-106 . https://doi.org/10.1016/j.tcm.2021.10.009
Trends in Cardiovascular Medicine, 33, 92-106
Volleberg, R, Mol, J Q, van der Heijden, D, Meuwissen, M, van Leeuwen, M, Escaned, J, Holm, N, Adriaenssens, T, van Geuns, R J, Tu, S, Crea, F, Stone, G & van Royen, N 2023, ' Optical coherence tomography and coronary revascularization : from indication to procedural optimization ', Trends in Cardiovascular Medicine, vol. 33, no. 2, pp. 92-106 . https://doi.org/10.1016/j.tcm.2021.10.009
Angiography alone is the most commonly used imaging modality for guidance of percutaneous coronary interventions. Angiography is limited, however, by several factors, including that it only portrays a low resolution, two-dimensional outline of the lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28195da450f3814736a0eb9bcebad1c9
Publikováno v:
Journal of Interventional Cardiology, 2020
Journal of Interventional Cardiology, 2020:8821525. Wiley-Blackwell Publishing Ltd
Mol, J Q, Bom, M J, Damman, P, Knaapen, P & Van Royen, N 2020, ' Pre-Emptive OCT-Guided Angioplasty of Vulnerable Intermediate Coronary Lesions : Results from the Prematurely Halted PECTUS-Trial ', Journal of Interventional Cardiology, vol. 2020, 8821525 . https://doi.org/10.1155/2020/8821525
Journal of Interventional Cardiology
Journal of Interventional Cardiology, Vol 2020 (2020)
Journal of Interventional Cardiology, 2020:8821525. Wiley-Blackwell Publishing Ltd
Mol, J Q, Bom, M J, Damman, P, Knaapen, P & Van Royen, N 2020, ' Pre-Emptive OCT-Guided Angioplasty of Vulnerable Intermediate Coronary Lesions : Results from the Prematurely Halted PECTUS-Trial ', Journal of Interventional Cardiology, vol. 2020, 8821525 . https://doi.org/10.1155/2020/8821525
Journal of Interventional Cardiology
Journal of Interventional Cardiology, Vol 2020 (2020)
Contains fulltext : 235383.pdf (Publisher’s version ) (Open Access) OBJECTIVES: To assess the safety and efficacy of pre-emptive treatment of optical coherence tomography- (OCT-) derived vulnerable, non-flow-limiting, non-culprit lesions in patient
Autor:
Niels van Royen, Oleg V Krestyaninov, Karin Arkenbout, Martijn Meuwissen, Maarten A.H. van Leeuwen, Alexey V Protopopov, Peep Laanmets, R.M. Oemrawsingh, Jan-Quinten Mol, Anouar Belkacemi, Rick Hja Volleberg, Robert-Jan van Geuns, Erik Lipsic, Dirk J. van der Heijden, Jan-Peter van Kuijk, Peter Damman, Cyril Camaro, Steven Teerenstra, Robert Dennert, Saman Rasoul
Publikováno v:
BMJ Open
BMJ Open, 11(7):e048994. BMJ Publishing Group
BMJ Open, Vol 11, Iss 7 (2021)
BMJ Open, 11
BMJ Open, 11(7):048994. BMJ PUBLISHING GROUP
BMJ Open, 11, 7
BMJ Open, 11(7):e048994. BMJ Publishing Group
BMJ Open, Vol 11, Iss 7 (2021)
BMJ Open, 11
BMJ Open, 11(7):048994. BMJ PUBLISHING GROUP
BMJ Open, 11, 7
IntroductionIn patients with myocardial infarction, the decision to treat a nonculprit lesion is generally based on its physiological significance. However, deferral of revascularisation based on nonischaemic fractional flow reserve (FFR) values in t
Autor:
D. H. Frank Gommans, Joris Nas, Sara-Joan Pinto-Sietsma, Yvonne Koop, Regina E. Konst, Frans Mensink, Goaris W.A. Aarts, Lara S.F. Konijnenberg, Kimberley Cortenbach, Dominique V.M. Verhaert, Jos Thannhauser, Jan-Quinten Mol, Maxim J.P. Rooijakkers, Jacqueline L. Vos, Anouke van Rumund, Priya Vart, Robert-Jan Hassing, Jan-Hein Cornel, C. Peter C. de Jager, Michel M. van den Heuvel, Hans G. van der Hoeven, Annelies Verbon, Yigal M. Pinto, Niels van Royen, Roland R.J. van Kimmenade, Peter W. de Leeuw, Michiel A. van Agtmael, Paul Bresser, Wiek H. van Gilst, Anton Vonk-Noordergraaf, Jan G.P. Tijssen
Publikováno v:
American Heart Journal
American heart journal, 226, 60-68. Mosby Inc.
American Heart Journal, 226, pp. 60-68
Gommans, D H F, Nas, J, Pinto-Sietsma, S J, Koop, Y, Konst, R E, Mensink, F, Aarts, G W A, Konijnenberg, L S F, Cortenbach, K, Verhaert, D V M, Thannhauser, J, Mol, J Q, Rooijakkers, M J P, Vos, J L, van Rumund, A, Vart, P, Hassing, R J, Cornel, J H, de Jager, C P C, van den Heuvel, M M, van der Hoeven, H G, Verbon, A, Pinto, Y M, van Royen, N, van Kimmenade, R R J, de Leeuw, P W, van Agtmael, M A, Bresser, P, van Gilst, W H, Vonk-Noordergraaf, A, Tijssen, J G P, Event committee, Data Safety Monitoring Board & Steering committee 2020, ' Rationale and design of the PRAETORIAN-COVID trial : A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease: PRAETORIAN-COVID (NCT04335786) ', American Heart Journal, vol. 226, pp. 60-68 . https://doi.org/10.1016/j.ahj.2020.05.010
American Heart Journal, 226, 60-68. MOSBY-ELSEVIER
American Heart Journal, 226, 60-68. Mosby Inc.
American Heart Journal, 226, 60-68
American heart journal, 226, 60-68. Mosby Inc.
American Heart Journal, 226, pp. 60-68
Gommans, D H F, Nas, J, Pinto-Sietsma, S J, Koop, Y, Konst, R E, Mensink, F, Aarts, G W A, Konijnenberg, L S F, Cortenbach, K, Verhaert, D V M, Thannhauser, J, Mol, J Q, Rooijakkers, M J P, Vos, J L, van Rumund, A, Vart, P, Hassing, R J, Cornel, J H, de Jager, C P C, van den Heuvel, M M, van der Hoeven, H G, Verbon, A, Pinto, Y M, van Royen, N, van Kimmenade, R R J, de Leeuw, P W, van Agtmael, M A, Bresser, P, van Gilst, W H, Vonk-Noordergraaf, A, Tijssen, J G P, Event committee, Data Safety Monitoring Board & Steering committee 2020, ' Rationale and design of the PRAETORIAN-COVID trial : A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease: PRAETORIAN-COVID (NCT04335786) ', American Heart Journal, vol. 226, pp. 60-68 . https://doi.org/10.1016/j.ahj.2020.05.010
American Heart Journal, 226, 60-68. MOSBY-ELSEVIER
American Heart Journal, 226, 60-68. Mosby Inc.
American Heart Journal, 226, 60-68
Background There is much debate on the use of angiotensin receptor blockers (ARBs) in severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-infected patients. Although it has been suggested that ARBs might lead to a higher susceptibility and s
Autor:
Joris Nas, Jos Thannhauser, Priya Vart, J. Vos, Judith L. Bonnes, Hella E C Muijsers, Lara S. F. Konijnenberg, Frank Gommans, Marc A. Brouwer, Sandra G.A.M. Ahoud-Schoenmakers, Robert-Jan van Geuns, Jan Quinten Mol, Niels van Royen, Goaris W.A. Aarts
Publikováno v:
JAMA Cardiol
JAMA Cardiology, 5, 3, pp. 328-335
JAMA Cardiology, 5, 328-335
JAMA Cardiology, 5, 3, pp. 328-335
JAMA Cardiology, 5, 328-335
IMPORTANCE: Bystander cardiopulmonary resuscitation (CPR) is crucial for survival after cardiac arrest but not performed in most cases. New, low-cost, and easily accessible training methods, such as virtual reality (VR), may reach broader target popu